AD

Financial statements Van Hessen Pharma Poland

Balance sheet of Van Hessen Pharma Poland

Company age:
Age:
16 y. 7 m. 3 d.
Share capital:
Share capital:
50 000 PLN
Profit and loss statement Balance Cash flow Profitability

Balance sheet data of VAN HESSEN PHARMA POLAND

Year
2019
2020
2021
2022
2023
Total assets 47 404 186,85 39 727 561,15 41 862 510,67 68 236 563,34 70 539 298,49
A. Fixed assets 9 768 887,16 9 222 898,68 8 736 095,87 8 821 569,22 7 923 005,58
B. Current assets 37 635 299,69 30 504 662,47 33 126 414,80 59 414 994,12 62 616 292,91
C. Share capital contributions (basic funds) 0,00 0,00 0,00 0,00 0,00
D. Own shares (stocks) 0,00 0,00 0,00 0,00 0,00
Total liabilities 47 404 186,85 39 727 561,15 41 862 510,67 68 236 563,34 70 539 298,49
A. Equity 21 412 015,40 29 960 196,89 21 302 228,55 34 112 890,37 52 535 450,20
B. Liabilities and provisions for liabilities 25 992 171,45 9 767 364,26 20 560 282,12 34 123 672,97 18 003 848,29
I. Long-term liabilities 492 208,15 421 742,86 334 974,40 680 910,47 311 286,62
II. Short-term liabilities 24 963 952,96 8 820 770,53 19 784 965,84 33 185 637,72 17 584 018,51
Financial data is automatically retrieved from the EKRS webpage of the Ministry of Justice.
  • Fixed Assets - Assets held for a longer period, typically longer than a year, such as real estate or machinery.
  • Current Assets - Assets intended to be used or sold within a year, such as inventory, receivables, and cash.
  • Equity - The net value of a company's assets, representing the difference between its assets and liabilities.
  • Long-Term Liabilities - Financial obligations to be repaid over a period longer than a year, such as loans or bonds.
  • Short-Term Liabilities - Financial obligations to be repaid within a year, such as payables to suppliers or short-term loans.
  • Reserve Capital - A portion of equity set aside for specific purposes, such as covering losses or business development.
AD
AD